Search for: "BAYER HEALTHCARE PHARMACEUTICALS INC. V. WATSON PHARMACEUTICAL, INC. "
Results 1 - 11
of 11
Sorted by Relevance
|
Sort by Date
24 Apr 2013, 9:46 pm
By Michael Greenfield -- Contraceptives were the subject of the Federal Circuit's recent decision in Bayer Healthcare Pharmaceuticals, Inc. v. [read post]
19 Feb 2012, 8:55 pm
Watson Pharmaceuticals, Inc. et al. 2:12-cv-00223; filed February 13, 2012 in the District Court of Nevada • Plaintiffs: Merck & Cie; Bayer Pharma AG; Bayer Healthcare Pharmaceuticals Inc. [read post]
25 Apr 2013, 12:15 pm
In Bayer Healthcare Pharmaceuticals, Inc. v. [read post]
9 Oct 2009, 9:11 am
(patent infringement) 9/15: Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals Inc., Schering Corporation v. [read post]
17 Feb 2010, 8:00 am
Bayer Healthcare LLC (patent infringement) 1/5: Cephalon Inc. and Cephalon France v. [read post]
22 Aug 2013, 1:34 pm
The Pliva, Inc., et al. v. [read post]
28 Jul 2010, 12:06 am
Watson Laboratories, Inc. [read post]
22 Jun 2011, 4:09 am
Highlights this week included: US Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods: Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) Baytril (Enrofloxacin) – US: In a rare move, District Court extends 30-month stay on FDA ANADA approval: Bayer Healthcare v Norbrook (FDA Law Blog) Europe seizure of generic drugs: Lilly settles with Indian generics (Generic… [read post]
6 Apr 2011, 12:18 am
Chiron Healthcare & Novartis (EPLAW) India firm on ‘NO’ to data exclusivity (SiNApSE) (Generic Pharmaceuticals and IP) (Spicy IP) (Spicy IP) US: CAFC hears oral arguments on patentability of DNA claims: American Molecular Pathology, et. al, v. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
